Goldman Sachs’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.39M | Buy |
3,039,783
+963,835
| +46% | +$2.98M | ﹤0.01% | 2318 |
|
|
2025
Q1 | $7.25M | Buy |
2,075,948
+1,544,070
| +290% | +$5.39M | ﹤0.01% | 2467 |
|
|
2024
Q4 | $1.74M | Sell |
531,878
-28,529
| -5% | -$93.3K | ﹤0.01% | 3569 |
|
|
2024
Q3 | $2.16M | Buy |
560,407
+403,078
| +256% | +$1.55M | ﹤0.01% | 3320 |
|
|
2024
Q2 | $486K | Sell |
157,329
-17,376
| -10% | -$53.7K | ﹤0.01% | 3971 |
|
|
2024
Q1 | $451K | Buy |
174,705
+48,115
| +38% | +$124K | ﹤0.01% | 4037 |
|
|
2023
Q4 | $316K | Sell |
126,590
-78,049
| -38% | -$195K | ﹤0.01% | 4155 |
|
|
2023
Q3 | $415K | Sell |
204,639
-17,477
| -8% | -$35.5K | ﹤0.01% | 3959 |
|
|
2023
Q2 | $511K | Sell |
222,116
-48,477
| -18% | -$111K | ﹤0.01% | 3968 |
|
|
2023
Q1 | $820K | Sell |
270,593
-113,378
| -30% | -$344K | ﹤0.01% | 3796 |
|
|
2022
Q4 | $895K | Sell |
383,971
-267,065
| -41% | -$622K | ﹤0.01% | 3754 |
|
|
2022
Q3 | $1.24M | Sell |
651,036
-80,129
| -11% | -$153K | ﹤0.01% | 3699 |
|
|
2022
Q2 | $1.98M | Sell |
731,165
-810,020
| -53% | -$2.2M | ﹤0.01% | 3457 |
|
|
2022
Q1 | $4.59M | Buy |
1,541,185
+847,914
| +122% | +$2.53M | ﹤0.01% | 2867 |
|
|
2021
Q4 | $2.7M | Buy |
693,271
+406,635
| +142% | +$1.58M | ﹤0.01% | 3277 |
|
|
2021
Q3 | $1.23M | Buy |
286,636
+182,152
| +174% | +$782K | ﹤0.01% | 3833 |
|
|
2021
Q2 | $317K | Buy |
104,484
+59,845
| +134% | +$182K | ﹤0.01% | 4674 |
|
|
2021
Q1 | $149K | Sell |
44,639
-14,611
| -25% | -$48.8K | ﹤0.01% | 4936 |
|
|
2020
Q4 | $210K | Sell |
59,250
-194,865
| -77% | -$691K | ﹤0.01% | 4250 |
|
|
2020
Q3 | $795K | Sell |
254,115
-1,410,216
| -85% | -$4.41M | ﹤0.01% | 3437 |
|
|
2020
Q2 | $3.03M | Sell |
1,664,331
-273,998
| -14% | -$499K | ﹤0.01% | 2618 |
|
|
2020
Q1 | $1.96M | Buy |
1,938,329
+1,852,238
| +2,151% | +$1.87M | ﹤0.01% | 2775 |
|
|
2019
Q4 | $239K | Sell |
86,091
-18,137
| -17% | -$50.4K | ﹤0.01% | 3930 |
|
|
2019
Q3 | $159K | Sell |
104,228
-96,508
| -48% | -$147K | ﹤0.01% | 3970 |
|
|
2019
Q2 | $418K | Sell |
200,736
-19,914
| -9% | -$41.5K | ﹤0.01% | 3592 |
|
|
2019
Q1 | $790K | Buy |
220,650
+133,253
| +152% | +$477K | ﹤0.01% | 3369 |
|
|
2018
Q4 | $334K | Sell |
87,397
-3,195
| -4% | -$12.2K | ﹤0.01% | 3562 |
|
|
2018
Q3 | $856K | Sell |
90,592
-262,746
| -74% | -$2.48M | ﹤0.01% | 3252 |
|
|
2018
Q2 | $2.58M | Buy |
353,338
+246,668
| +231% | +$1.8M | ﹤0.01% | 2770 |
|
|
2018
Q1 | $533K | Buy |
106,670
+52,148
| +96% | +$261K | ﹤0.01% | 3472 |
|
|
2017
Q4 | $275K | Buy |
+54,522
| New | +$275K | ﹤0.01% | 3687 |
|
|
2017
Q3 | – | Sell |
-91,706
| Closed | -$330K | – | 4255 |
|
|
2017
Q2 | $330K | Sell |
91,706
-149,970
| -62% | -$540K | ﹤0.01% | 3748 |
|
|
2017
Q1 | $785K | Sell |
241,676
-122,470
| -34% | -$398K | ﹤0.01% | 3249 |
|
|
2016
Q4 | $892K | Sell |
364,146
-246,302
| -40% | -$603K | ﹤0.01% | 3148 |
|
|
2016
Q3 | $2.1M | Sell |
610,448
-70,098
| -10% | -$241K | ﹤0.01% | 2686 |
|
|
2016
Q2 | $2.37M | Sell |
680,546
-68,185
| -9% | -$237K | ﹤0.01% | 2518 |
|
|
2016
Q1 | $3.09M | Buy |
748,731
+73,675
| +11% | +$304K | ﹤0.01% | 2307 |
|
|
2015
Q4 | $3M | Sell |
675,056
-29,529
| -4% | -$131K | ﹤0.01% | 2316 |
|
|
2015
Q3 | $4.29M | Sell |
704,585
-68,993
| -9% | -$420K | ﹤0.01% | 2100 |
|
|
2015
Q2 | $9.18M | Buy |
773,578
+282,796
| +58% | +$3.35M | ﹤0.01% | 1731 |
|
|
2015
Q1 | $8.57M | Buy |
+490,782
| New | +$8.57M | ﹤0.01% | 1754 |
|
|
2014
Q4 | – | Sell |
-9,512
| Closed | -$201K | – | 4528 |
|
|
2014
Q3 | $201K | Buy |
9,512
+5,445
| +134% | +$115K | ﹤0.01% | 3947 |
|
|
2014
Q2 | $53K | Sell |
4,067
-6,143
| -60% | -$80.1K | ﹤0.01% | 4280 |
|
|
2014
Q1 | $219K | Sell |
10,210
-4,347
| -30% | -$93.2K | ﹤0.01% | 3877 |
|
|
2013
Q4 | $116K | Buy |
+14,557
| New | +$116K | ﹤0.01% | 4053 |
|